Some experts worry that deepening civil-military ties could pose problems.
OpenAI will still let researchers use the model.
Microsoft has expanded its ongoing partnership with San Francisco-based artificial intelligence research company OpenAI with a new exclusive license on the AI firm’s groundbreaking GPT-3 language model, an auto-generating text program that’s emerged as the most sophisticated of its kind in the industry.
The two companies are already entwined through OpenAI’s ongoing Azure cloud computing contract, with Azure being the platform on which OpenAI accesses the vast computing resources it needs to train many of its models, and a major $1 billion investment Microsoft made last year to become OpenAI’s exclusive cloud provider. Now, Microsoft is issuing yet another signal of high confidence in OpenAI’s research by acquiring the rights to GPT-3.
OpenAI released GPT-3, the third iteration of its ever-growing language model, in July, and the program and its prior iterations have helped create some of the most fascinating AI language experiments to date. It’s also inspired vigorous debate around the ethics of powerful AI programs that may be used for more nefarious purposes, with OpenAI initially refusing to publish research about the model for fear it would be misused.
While critically ill patients experience a life-threatening illness, they commonly contract ventilator-associated pneumonia. This nosocomial infection increases morbidity and likely mortality as well as the cost of health care. This article reviews the literature with regard to diagnosis, treatment, and prevention. It provides conclusions that can be implemented in practice as well as an algorithm for the bedside clinician and also focuses on the controversies with regard to diagnostic tools and approaches, treatment plans, and prevention strategies.
Patients in the intensive care unit (ICU) are at risk for dying not only from their critical illness but also from secondary processes such as nosocomial infection. Pneumonia is the second most common nosocomial infection in critically ill patients, affecting 27% of all critically ill patients (170). Eighty-six percent of nosocomial pneumonias are associated with mechanical ventilation and are termed ventilator-associated pneumonia (VAP). Between 250,000 and 300,000 cases per year occur in the United States alone, which is an incidence rate of 5 to 10 cases per 1,000 hospital admissions (134, 170). The mortality attributable to VAP has been reported to range between 0 and 50% (10, 41, 43, 96, 161).
A new type of air filter has the potential to work faster, cheaper and better than any other, killing virtually all airborne bacteria and viruses in a fraction of a second.
It’s a germaphobes dream, and a bullish weapon against the spread of infectious diseases, some of which, like measles, can remain suspended in the air for hours on end.
The new device is not only effective at killing viruses, it can actually prevent disease. And if the technology can be miniaturised, the authors say it may one day replace the century-old face mask, allowing us to breathe clean air on the fly.
Blue Origin just announced the timing of its next rocket launch — and it’s surprisingly soon, in just two days, on Thursday, September 24. The launch of Blue Origin’s New Shepard vehicle will be its thirteenth overall for that category of launch craft, and the seventh in a row for this particular rocket. The payload will include an even dozen commercial cargo items, including a Deorbit, Descent and Landing Sensor Demonstration done in partnership with NASA — basically a highly precise automated landing system that will help NASA land on the moon and eventually Mars.
That payload is unique not just because of the technology involved in the landing system, but also because it’ll actually be mounted to the exterior of the New Shephard’s booster stage, rather than in the capsule that rides atop it. This is the first time that Blue Origin has carried a payload this way, and the company expects it could pave the way for similar future missions, enabling sensing at high altitudes, and experiments made possible through use of equipment exposed to the external environment.
Las Vegas hosted two successful test flights using unmanned aircraft to carry human organs and tissue last week. On Sept. 17th, MissionGo, a provider of unmanned aviation solutions and Nevada Donor Network, conducted two unmanned flights — one of which was the longest organ delivery flight in Unmanned Aircraft System (UAS) history. The first flight involved transport of research corneas fromSouthern Hills Hospital and Medical Center to Dignity Health — St. Rose Dominican, San Martín Campus.
Two years after Bezos said he would create a network of preschools, the first of those schools, called Bezos Academy, will open south of Seattle in October.
Following a series of critical contract awards and hardware milestones, NASA has shared an update on its Artemis program, including the latest Phase 1 plans to land the first woman and the next man on the surface of the Moon in 2024.
US space agency NASA has forecast a recently-spotted asteroid, 2020 SW, for a fly-by on Thursday. It will fly by at an agonising distance of around 17,000 miles – closer than a weather satellite.